Metabolic activation of carcinogens. 1992

F P Guengerich
Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN 37232-0146.

Most chemical carcinogens are not active in themselves but require bioactivation to electrophiles that bind covalently to DNA and often act by producing mutations. In recent years it has been realized that mutations can be important at many stages of carcinogenesis. A variety of different enzymes are involved in bioactivation reactions, which include oxidation, reduction, thiol conjugation, acetyl transfer, sulfur transfer, methyl transfer, glucuronosyl transfer, and epoxide hydrolysis. These processes often occur in concert with a single carcinogen. Humans vary considerably in activities of these enzymes and this variation may contribute to differences in risk.

UI MeSH Term Description Entries
D002273 Carcinogens Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. Carcinogen,Oncogen,Oncogens,Tumor Initiator,Tumor Initiators,Tumor Promoter,Tumor Promoters,Initiator, Tumor,Initiators, Tumor,Promoter, Tumor,Promoters, Tumor
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001711 Biotransformation The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.

Related Publications

F P Guengerich
January 1986, Progress in clinical and biological research,
F P Guengerich
January 1982, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques,
F P Guengerich
January 1988, Annals of the New York Academy of Sciences,
F P Guengerich
January 1980, British medical bulletin,
F P Guengerich
September 1988, Human toxicology,
F P Guengerich
January 1980, Journal of toxicology and environmental health,
F P Guengerich
November 1975, Mutation research,
F P Guengerich
January 2000, Journal of the National Cancer Institute. Monographs,
F P Guengerich
January 1979, The Italian journal of biochemistry,
F P Guengerich
January 1990, Chemico-biological interactions,
Copied contents to your clipboard!